홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Nalbuphine Hydrochloride

HCID 5360733
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
23277-43-2
표준 SMILES
Cl.Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314
InChIKey
YZLZPSJXMWGIFH-BCXQGASESA-N
분자식
C21H28ClNO4
평균 분자량
393.9 g/mol
단동위원소 질량
393.17068606

개요

Nalbuphine Hydrochloride is the hydrochloride salt form of nalbuphine, a synthetic phenanthrene opioid with opiate agonist and antagonist effects, used to treat moderate to severe pain and provide preoperative and postoperative analgesia and sedation. Nalbuphine hydrochloride binds to kappa-, mu- and delta-opioid receptors but not to sigma-opioid receptors. This opioid exerts its analgesic actions primarily through kappa-opioid-receptor agonism and partially through mu-opioid receptor agonism.

이름 및 식별자

우선 이름
Nalbuphine Hydrochloride
IUPAC
(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol;hydrochloride

이름 및 동의어

NALBUPHINE HYDROCHLORIDE23277-43-2Nalbuphine HCLEN-2234ANalbufine hydrochlorideEn 2234ANalbufina clorhidratoNSC-757829ZU4275277RDTXSID20177844(5alpha,6alpha)-17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochlorideN-Cyclobutylmethyl-14-hydroxydihydronormorphine hydrochloride
이름 더 보기
CHEBI:7455NALBUPHINE HCIRefChem:57231DTXCID80100335EN2234A245-549-917-cyclobutylmethyl-4,5alpha-epoxymorphinan-3,6alpha,14-triol hydrochlorideNubain

데이터베이스 식별자

CAS
23277-43-2
PubChem CID
5360733
DTXSID
DTXSID20177844
ChEMBL
CHEMBL1201132
UNII
ZU4275277R
EC Number
245-549-9

물성

구조 계산 물성

극성 표면적
73.2 Ų
수소 결합 공여자 수
4
수소 결합 수용자 수
5
회전 가능 결합 수
2
무거운 원자 수
27
형식 전하
0
복잡도
597

실험 및 물리화학적 성질

Human Drugs · 2건

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section180.8 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H300 (63.9%): Fatal if swallowed [Danger Acute toxicity, oral]

P233, P260, P261, P262, P264, P270, P271, P272, P280, P284, P301+P316, P301+P317, P302+P352, P304+P340, P316, P317, P320, P321, P330, P333+P317, P342+P316, P361+P364, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 61 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory InformationStatus: Active Update: 19-06-2017 https://echa.europa.eu/registration-dossier/-/registered-dossier/20141
Hazard Classes and CategoriesAcute Tox. 2 (63.9%)

독성 정보

Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Nalbuphine hydrochloride

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

화학 및 산업

약리 정보

FDA Pharmacological Classification · 4건

NALBUPHINE HCI

Competitive Opioid Antagonists [MoA]; Partial Opioid Agonists [MoA]; Opioid Agonist/Antagonist [EPC]

NALBUPHINE HYDROCHLORIDE

Opioid Agonist/Antagonist [EPC]; Partial Opioid Agonists [MoA]; Competitive Opioid Antagonists [MoA]

MeSH Pharmacological ClassificationCompounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS.

관련 반응

1건
반응 기록 만들기
HRID 533703 반응식
HRID 533703생성물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트